Text

Resistance to Targeted Therapies Against Adult Brain Cancers

---

This volume will bring together a review of research being carried out by international experts in this field, detailing treatment and research approaches in several forms of malignant brain tumors. These include glioblastoma (GBM), a highly aggressive and fatal form of astrocytoma which accounts for 80% of newly diagnosed brain tumor patients per year, and meningioma, of which 10% are malignant and extremely resistant to targeted therapies. The volume will also include a discussion of methods to overcome blood-brain barrier exclusion for more efficient targeted drug delivery in all forms of brain cancer treatment. The volume will include information on the repurposing of drugs in an attempt to circumvent drug resistance, use of small molecule inhibitors in GBM treatment, mechanisms of secondary brain metastasis, drug resistance, and state-of-the-art imaging of targeted therapies.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

-

Publisher

Cham, Switzerland : Springer Cham., 2016

Collation

-

Language

English

ISBN/ISSN

978-3-319-46505-0

Classification

NONE

Content Type

text

Media Type

computer

Carrier Type

online resource

Edition

Ed. 1

Subject(s)

Cancer Research

Specific Detail Info

-

Statement of Responsibility

Amanda Tivnan

Other Information

Cataloger

Firli

Source

https://link.springer.com/book/10.1007/978-3-319-46505-0#book-header

Validator

maya

Digital Object Identifier (DOI)

-

Journal Volume

-

Journal Issue

-

Subtitle

-

Parallel Title

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment